Multimodal micro, nano, and size conversion ultrasound agents for imaging and therapy

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 8, Issue 6, 2016, Pages 796-813

  Huynh, Elizabeth ^a,b   Rajora, Maneesha A ^a,c   Zheng, Gang ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMOBILE MANUFACTURE; IMAGING TECHNIQUES; MEDICAL IMAGING; NANOTECHNOLOGY; ULTRASONICS;

CANCER IMAGING; CONTRAST AGENT; DRUG DELIVERY VEHICLES; IN-VIVO; MICROSCALE AND NANOSCALE; MULTI-MODAL; MULTI-MODALITY; NANO SCALE;

DRUG INTERACTIONS;

ECHO CONTRAST MEDIUM; NANOBUBBLE; UPCONVERSION NANOPARTICLE; CONTRAST MEDIUM; NANOPARTICLE;

ECHOGRAPHY; HUMAN; MICROBUBBLE; MULTIMODAL IMAGING; NANOIMAGING; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; THERANOSTIC NANOMEDICINE; ANIMAL; MOUSE;

ANIMALS; CONTRAST MEDIA; HUMANS; MICE; NANOPARTICLES; THERANOSTIC NANOMEDICINE; ULTRASONOGRAPHY;

EID: 84961858338     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1398     Document Type: Review

References (96)

1. Moghimi SM, Porter CJ, Muir IS, Illum L, Davis SS. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991, 177:861–866.
2. Roerdink F, Regts J, Van Leeuwen B, Scherphof G. Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats. Biochim Biophys Acta 1984, 770:195–202.
3. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387–6392.
4. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473–483.
5. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000, 35:58–71.
6. Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res 1994, 74:1157–1165.
7. Wilson SR, Burns PN. Microbubble-enhanced US in body imaging: what role? Radiology 2010, 257:24–39.
8. Dindyal S, Kyriakides C. Ultrasound microbubble contrast and current clinical applications. Recent Pat Cardiovasc Drug Discov 2011, 6:27–41.
9. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol 2009, 193:86–95.
10. Weskott HP. Emerging roles for contrast-enhanced ultrasound. Clin Hemorheol Microcirc 2008, 40:51–71.
11. Huynh E, Zheng G. Engineering multifunctional nanoparticles: all-in-one versus one-for-all. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5:250–265.
12. Jin Y, Jia C, Huang SW, O'Donnell M, Gao X. Multifunctional nanoparticles as coupled contrast agents. Nat Commun 2010, 1:41.
13. Kabalnov A, Bradley J, Flaim S, Klein D, Pelura T, Peters B, Otto S, Reynolds J, Schutt E, Weers J. Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment. Ultrasound Med Biol 1998, 24:751–760.
14. Kabalnov A, Klein D, Pelura T, Schutt E, Weers J. Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. Ultrasound Med Biol 1998, 24:739–749.
15. Chomas JE, Dayton P, May D, Ferrara K. Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt 2001, 6:141–150.
16. Burns PN, Hope Simpson D, Averkiou MA. Nonlinear imaging. Ultrasound Med Biol 2000, 26(Suppl 1):S19–22.
17. Lentacker I, De Cock I, Deckers R, De Smedt SC, Moonen CT. Understanding ultrasound induced sonoporation: definitions and underlying mechanisms. Adv Drug Deliv Rev 2014, 72:49–64.
18. van Wamel A, Bouakaz A, Versluis M, de Jong N. Micromanipulation of endothelial cells: ultrasound-microbubble-cell interaction. Ultrasound Med Biol 2004, 30:1255–1258.
19. van Wamel A, Kooiman K, Harteveld M, Emmer M, ten Cate FJ, Versluis M, de Jong N. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 2006, 112:149–155.
20. Juffermans LJ, van Dijk A, Jongenelen CA, Drukarch B, Reijerkerk A, de Vries HE, Kamp O, Musters RJ. Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med Biol 2009, 35:1917–1927.
21. Kumon RE, Aehle M, Sabens D, Parikh P, Kourennyi D, Deng CX. Ultrasound-induced calcium oscillations and waves in Chinese hamster ovary cells in the presence of microbubbles. Biophys J 2007, 93:L29–31.
22. Kumon RE, Aehle M, Sabens D, Parikh P, Han YW, Kourennyi D, Deng CX. Spatiotemporal effects of sonoporation measured by real-time calcium imaging. Ultrasound Med Biol 2009, 35:494–506.
23. Apodaca G. Modulation of membrane traffic by mechanical stimuli. Am J Physiol Renal Physiol 2002, 282:F179–190.
24. Lionetti V, Fittipaldi A, Agostini S, Giacca M, Recchia FA, Picano E. Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. Ultrasound Med Biol 2009, 35:136–143.
25. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353:1409.
26. Postema M, van Wamel A, Lancee CT, de Jong N. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol 2004, 30:827–840.
27. Postema M, van Wamel A, ten Cate FJ, de Jong N. High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles. Med Phys 2005, 32:3707–3711.
28. Tran TA, Roger S, Le Guennec JY, Tranquart F, Bouakaz A. Effect of ultrasound-activated microbubbles on the cell electrophysiological properties. Ultrasound Med Biol 2007, 33:158–163.
29. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008, 60:1193–1208.
30. Geis NA, Katus HA, Bekeredjian R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des 2012, 18:2166–2183.
31. Mayer CR, Geis NA, Katus HA, Bekeredjian R. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 2008, 5:1121–1138.
32. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007, 9:415–447.
33. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006, 41:354–362.
34. Lum AF, Borden MA, Dayton PA, Kruse DE, Simon SI, Ferrara KW. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release 2006, 111:128–134.
35. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003, 108:1022–1026.
36. Korpanty G, Chen S, Shohet RV, Ding J, Yang B, Frenkel PA, Grayburn PA. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther 2005, 12:1305–1312.
37. Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol 2004, 30:539–543.
38. Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, Tachibana K, Ogihara T, Morishita R. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005, 7:108–116.
39. Shimamura M, Sato N, Taniyama Y, Kurinami H, Tanaka H, Takami T, Ogihara T, Tohyama M, Kaneda Y, Morishita R. Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles. J Gene Med 2005, 7:1468–1474.
40. Tartis MS, Kruse DE, Zheng H, Zhang H, Kheirolomoom A, Marik J, Ferrara KW. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J Control Release 2008, 131:160–166.
41. Barrefelt AAB TB, Egri G, Aspelin P, Olsson A, Oddo L, Margheritelli S, Caidahl K, Paradossi G, Dahne L, Axelsson R, et al. Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles. EJNMMI Res 2013, 3:1–14.
42. Barrefelt A, Zhao Y, Larsson MK, Egri G, Kuiper RV, Hamm J, Saghafian M, Caidahl K, Brismar TB, Aspelin P, et al. Fluorescence labeled microbubbles for multimodal imaging. Biochem Biophys Res Commun 2015, 464:737–742.
43. Yang F, Li Y, Chen Z, Zhang Y, Wu J, Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009, 30:3882–3890.
44. Moghissi K, Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technol Cancer Res Treat 2003, 2:319–326.
45. Xu B, Lu R, Dou H, Tao K, Sun K, Qiu Y, Ding J, Zhang D, Li J, Shi W, et al. Exploring the structure–property relationships of ultrasonic/MRI dual imaging magnetite/PLA microbubbles: magnetite@Cavity versus magnetite@Shell systems. Colloid Polym Sci 2012, 290:1617–1626.
46. Teraphongphom N, Chhour P, Eisenbrey JR, Naha PC, Witschey WR, Opasanont B, Jablonowski L, Cormode DP, Wheatley MA. Nanoparticle loaded polymeric microbubbles as contrast agents for multimodal imaging. Langmuir 2015, 31:11858–11867.
47. Ao M, Wang Z, Ran H, Guo D, Yu J, Li A, Chen W, Wu W, Zheng Y. Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent—a feasibility research. J Biomed Mater Res B Appl Biomater 2010, 93:551–556.
48. Mlkvy P, Makovnik P, Majek J, Slezak P, Kollar T. Laser and photodynamic therapy for esophageal cancer. Bratisl Lek Listy 2003, 104:90–91.
49. Liu Z, Lammers T, Ehling J, Fokong S, Bornemann J, Kiessling F, Gatjens J. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 2011, 32:6155–6163.
50. Liu TY, Wu MY, Lin MH, Yang FY. A novel ultrasound-triggered drug vehicle with multimodal imaging functionality. Acta Biomater 2013, 9:5453–5463.
51. Feshitan JA, Vlachos F, Sirsi SR, Konofagou EE, Borden MA. Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery. Biomaterials 2012, 33:247–255.
52. Xu RX, Huang J, Xu JS, Sun D, Hinkle GH, Martin EW, Povoski SP. Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J Biomed Opt 2009, 14:034020.
53. Ke H, Xing Z, Zhao B, Wang J, Liu J, Guo C, Yue X, Liu S, Tang Z, Dai Z. Quantum-dot-modified microbubbles with bi-mode imaging capabilities. Nanotechnology 2009, 20:425105.
54. Jin B, Lin M, Zong Y, Wan M, Xu F, Duan Z, Lu T. Microbubble embedded with upconversion nanoparticles as a bimodal contrast agent for fluorescence and ultrasound imaging. Nanotechnology 2015, 26:345601.
55. Koczera P, Wu Z, Fokong S, Theek B, Appold L, Jorge S, Mockel D, Liu Z, Curaj A, Storm G, et al. Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies. Drug Deliv Transl Res 2012, 2:56–64.
56. Liu Z, Koczera P, Doleschel D, Kiessling F, Gatjens J. Versatile synthetic strategies for PBCA-based hybrid fluorescent microbubbles and their potential theranostic applications to cell labelling and imaging. Chem Commun (Camb) 2012, 48:5142–5144.
57. Kim C, Qin R, Xu JS, Wang LV, Xu R. Multifunctional microbubbles and nanobubbles for photoacoustic and ultrasound imaging. J Biomed Opt 2010, 15:010510.
58. Jeon M, Song W, Huynh E, Kim J, Kim J, Helfield BL, Leung BY, Goertz DE, Zheng G, Oh J, et al. Methylene blue microbubbles as a model dual-modality contrast agent for ultrasound and activatable photoacoustic imaging. J Biomed Opt 2014, 19:16005.
59. Dove JD, Murray TW, Borden MA. Enhanced photoacoustic response with plasmonic nanoparticle-templated microbubbles. Soft Matter 2013, 9:7743.
60. Huynh E, Lovell JF, Helfield BL, Jeon M, Kim C, Goertz DE, Wilson BC, Zheng G. Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties. J Am Chem Soc 2012, 134:16464–16467.
61. Huynh E, Jin CS, Wilson BC, Zheng G. Aggregate enhanced trimodal porphyrin shell microbubbles for ultrasound, photoacoustic, and fluorescence imaging. Bioconjug Chem 2014, 25:796–801.
62. Sun Y, Zheng Y, Ran H, Zhou Y, Shen H, Chen Y, Chen H, Krupka TM, Li A, Li P, et al. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation. Biomaterials 2012, 33:5854–5864.
63. Lammers T, Koczera P, Fokong S, Gremse F, Ehling J, Vogt M, Pich A, Storm G, van Zandvoort M, Kiessling F. Theranostic USPIO-loaded microbubbles for mediating and monitoring blood–brain barrier permeation. Adv Funct Mater 2015, 25:36–43.
64. Jiang C, Li X, Yan F, Wang Z, Jin Q, Cai F, Qian M, Liu X, Zhang L, Zheng H. Microfluidic-assisted formation of multifunctional monodisperse microbubbles for diagnostics and therapeutics. Micro Nano Lett 2011, 6:417.
65. Niu C, Wang Z, Lu G, Krupka TM, Sun Y, You Y, Song W, Ran H, Li P, Zheng Y. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials 2013, 34:2307–2317.
66. Moon H, Kang J, Sim C, Kim J, Lee H, Chang JH, Kim H. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy. J Control Release 2015, 218:63–71.
67. Wang YH, Liao AH, Chen JH, Wang CR, Li PC. Photoacoustic/ultrasound dual-modality contrast agent and its application to thermotherapy. J Biomed Opt 2012, 17:045001.
68. Ke H, Wang J, Dai Z, Jin Y, Qu E, Xing Z, Guo C, Yue X, Liu J. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Ed Engl 2011, 50:3017–3021.
69. Jin Y, Wang J, Ke H, Wang S, Dai Z. Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials 2013, 34:4794–4802.
70. Li X-D, Liang X-L, Yue X-L, Wang J-R, Li C-H, Deng Z-J, Jing L-J, Lin L, Qu E-Z, Wang S-M, et al. Imaging guided photothermal therapy using iron oxide loaded poly(lactic acid) microcapsules coated with graphene oxide. J Mater Chem B 2014, 2:217–223.
71. Yin T, Wang P, Li J, Zheng R, Zheng B, Cheng D, Li R, Lai J, Shuai X. Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas. Biomaterials 2013, 34:4532–4543.
72. Yin T, Wang P, Li J, Wang Y, Zheng B, Zheng R, Cheng D, Shuai X. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes. Biomaterials 2014, 35:5932–5943.
73. Misra SKG G, Jensen TW, Partha SR, Burdette EC, Pan D. Bi-modal cancer treatment utilizing therapeutic ultrasound and an engineered therapeutic nanobubble. RSC Adv 2015, 5:63839–63845.
74. Yang H, Deng L, Li T, Shen X, Yan J, Zuo L, Wu C, Liu Y. Multifunctional PLGA nanobubbles as theranostic agents: combining doxorubicin and P-gp siRNA co-delivery into human breast cancer cells and ultrasound cellular imaging. J Biomed Nanotechnol 2015, 11:2124–2136.
75. Cavalli R, Bisazza A, Trotta M, Argenziano M, Civra A, Donalisio M, Lembo D. New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization. Int J Nanomedicine 2012, 7:3309–3318.
76. Xu JS, Huang J, Qin R, Hinkle GH, Povoski SP, Martin EW, Xu RX. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. Biomaterials 2010, 31:1716–1722.
77. Mai L, Yao A, Li J, Wei Q, Yuchi M, He X, Ding M, Zhou Q. Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model. PLoS One 2013, 8:e61224.
78. Yang H, Cai W, Xu L, Lv X, Qiao Y, Li P, Wu H, Yang Y, Zhang L, Duan Y. Nanobubble-affibody: novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor. Biomaterials 2015, 37:279–288.
79. Huang HY, Liu HL, Hsu PH, Chiang CS, Tsai CH, Chi HS, Chen SY, Chen YY. A multitheragnostic nanobubble system to induce blood–brain barrier disruption with magnetically guided focused ultrasound. Adv Mater 2015, 27:655–661.
80. Gao Z, Kennedy AM, Christensen DA, Rapoport NY. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008, 48:260–270.
81. Ji G, Yang J, Chen J. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy. Int J Pharm 2014, 466:314–320.
82. Kripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol 2000, 26:1177–1189.
83. Rapoport N, Nam KH, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release 2011, 153:4–15.
84. Williams R, Wright C, Cherin E, Reznik N, Lee M, Gorelikov I, Foster FS, Matsuura N, Burns PN. Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer. Ultrasound Med Biol 2013, 39:475–489.
85. Matsunaga TO, Sheeran PS, Luois S, Streeter JE, Mullin LB, Banerjee B, Dayton PA. Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging. Theranostics 2012, 2:1185–1198.
86. Rapoport N. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4:492–510.
87. Lin CY, Javadi M, Belnap DM, Barrow JR, Pitt WG. Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy. Nanomedicine 2014, 10:67–76.
88. Wilson K, Homan K, Emelianov S. Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging. Nat Commun 2012, 3:618.
89. Jian J, Liu C, Gong Y, Su L, Zhang B, Wang Z, Wang D, Zhou Y, Xu F, Li P, et al. India ink incorporated multifunctional phase-transition nanodroplets for photoacoustic/ultrasound dual-modality imaging and photoacoustic effect based tumor therapy. Theranostics 2014, 4:1026–1038.
90. Hannah A, Luke G, Wilson K, Homan K, Emelianov S. Indocyanine green-loaded photoacoustic nanodroplets: dual contrast nanoconstructs for enhanced photoacoustic and ultrasound imaging. ACS Nano 2014, 8:250–259.
91. Zhao Y, Song W, Wang D, Ran H, Wang R, Yao Y, Wang Z, Zheng Y, Li P. Phase-shifted PFH@PLGA/Fe3O4 nanocapsules for MRI/US imaging and photothermal therapy with near-infrared irradiation. ACS Appl Mater Interfaces 2015, 7:14231–14242.
92. Paproski RJ, Forbrich A, Huynh E, Chen J, Lewis JD, Zheng G, Zemp RJ. Porphyrin nanodroplets: sub-micrometer ultrasound and photoacoustic contrast imaging agents. Small 2015, 12:371–380.
93. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 2013, 73:2412–2417.
94. Huynh E, Leung BY, Helfield BL, Shakiba M, Gandier JA, Jin CS, Master ER, Wilson BC, Goertz DE, Zheng G. In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. Nat Nanotechnol 2015, 10:325–332.
95. Lovell JF, Jin CS, Huynh E, MacDonald TD, Cao W, Zheng G. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. Angew Chem Int Ed Engl 2012, 51:2429–2433.
96. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, Chan WC, Cao W, Wang LV, Zheng G. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011, 10:324–332.